← FDA Drug Approvals (Drugs@FDA)
TAVNEOS
NDA · New Drug Application · Sponsor: CHEMOCENTRYX · Approved 2021-10-07
Drug application
- FDA Application #
NDA214487- Application type
- New Drug Application
- Brand name
- TAVNEOS
- Generic name
- AVACOPAN
- Active ingredients
- AVACOPAN
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- CHEMOCENTRYX
- Manufacturer
- ChemoCentryx, Inc.
- First approval
- 2021-10-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown